Month: March 2023

FactSet Appoints Elisha Wiesel to Board of Directors

Written by Customer Service on March 24, 2023. Posted in Public Companies.

NORWALK, Conn., March 24, 2023 (GLOBE NEWSWIRE) — FactSet Research Systems Inc. (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced the appointment of Elisha Wiesel to its Board of Directors. Wiesel is a founding partner and the Chief Risk Officer of ClearAlpha Technologies, an emerging investment manager. Previously, Wiesel spent 25 years at Goldman Sachs, including 15 years as a partner, innovating in software, markets and risk management. He also served as Chief Risk Officer of the Securities Division for seven years and as Chief Information Officer for three years. Wiesel is chair of Entrio, an Israeli financial technology start-up company. He is also chair of the Elie Wiesel Foundation. He graduated from Yale University with a B.S. in Computer Science. “I am honored...

Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Written by Customer Service on March 24, 2023. Posted in Earnings Releases And Operating Results.

Trudhesa® Achieved nTRx of Over 58.4K in 2022; nTRx Increased by 19.4% in Q4 vs. Q3 2022 Net Product Revenue Finished Year at $12.7 Million; Increased 62% in Q4 vs. Q3 2022 to $5 Million Impel to Host Investor Conference Call Today at 8:30 a.m. ET SEATTLE, March 24, 2023 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company with a mission to develop transformative therapies for people suffering from diseases with high unmet medical needs, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update. “We continued to see strong growth in Trudhesa® prescriptions as we moved into 2023. The Company’s priority objective is to maximize the growth potential of Trudhesa in a market where we already hold 4.3 percent of total...

High Arctic Declares Monthly Dividend and Provides PNG Update

Written by Customer Service on March 24, 2023. Posted in Dividend Reports And Estimates.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, March 24, 2023 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) “High Arctic” or the “Corporation” is pleased to announce that its Board of Directors has approved a monthly dividend payment of $0.005 per share to holders of common shares. The dividend is payable on April 14, 2023 to holders of High Arctic common shares of record at the close of business on March 31, 2023. The dividend is designated as an “eligible dividend” for Canadian Income Tax purposes. The Corporation is also pleased to announce the re-commencement of in-wellbore operations with Rig 103 in Papua New Guinea (“PNG”) as previously...

Waterborne Coatings Market size to reach USD 109.39 Bn by 2029 at a CAGR of 3.8 percent – Says Maximize Market Research

Written by Customer Service on March 24, 2023. Posted in Dividend Reports And Estimates.

Waterborne Coatings Market size is growing due to increasing construction activities rapid industrialization and urbanization across the world. Waterborne Coatings Market analysis was conducted by dividing the market into two main segments: Resin Type and Application. Pune, March 24, 2023 (GLOBE NEWSWIRE) — Maximize Market research, a global Material & Chemical market research firm, has published a competitive intelligence and market research report on the “Waterborne Coatings Market”. The total market opportunity for Waterborne Coatings was USD 81.17 Bn in 2021 and is expected to grow at 3.8 percent CAGR through the forecast period to reach USD 109.39 Bn by 2029. Waterborne Coatings Market Report Scope and Research MethodologyMarket Size in 2021 USD 81.17 Bn.Market Size in 2029 USD 109.39 Bn.CAGR 3.8 percent (2022-2029)Forecast...

UTStarcom Reports Unaudited Financial Results for Second Half and Full Year 2022

Written by Customer Service on March 24, 2023. Posted in Earnings Releases And Operating Results.

HANGZHOU, China, March 24, 2023 (GLOBE NEWSWIRE) — UTStarcom (“UT,” “UTStarcom” or the “Company”) (NASDAQ: UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results for the six months and full year ended December 31, 2022, and provided a business update. Business UpdateProgress in Collaboration with China Unicom Research Institute on Development of 5G Transport Network Solution. Following the completion of NOS v.1.x Phase 2 development (announced earlier), UTStarcom continued development with customer China Unicom Research Institute on a disaggregated networking solution for 5G transport networks. UT won two more RFPs from this customer in 2H 2022: an RFP for a v.2.x NOS development covering advanced features such as SRv6, the related protocol stack, various NOS platform improvements...

Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments

Written by Customer Service on March 24, 2023. Posted in Earnings Releases And Operating Results.

OXFORD, United Kingdom, March 24, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) (the Company, we or us), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases, autoimmunity and cancer, today announced its financial results for year end 2022 and an overview of the Company’s progress. “2022 represented an extremely active year at Vaccitech in which the company continued to advance its exciting pipeline and strengthen the infrastructure necessary to support this and future growth. We announced the completion of enrollment of three clinical trials, and initiated dosing in three new trials. This, combined with the announcement of new, state-of-the-art laboratories and offices in the US and the UK, and...

Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023

Written by Customer Service on March 24, 2023. Posted in Public Companies.

BOCA RATON, Fla., March 24, 2023 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the fourth quarter and full year ended December 31, 2022, before the market opens on Friday, March 31, 2023. Management will host a conference call and audio webcast on Friday, March 31, 2023, at 8:00 a.m. ET to discuss the Company’s financial results.Event: Fourth Quarter and Full Year 2022 Financial Results Conference CallDate: Friday, March 31, 2023Time: 8:00 a.m. Eastern TimeLive Call: 1-800-715-9871 (U.S. & Canada Toll-Free)Conference ID 6955959Webcast: RegisterFor interested individuals unable to join the conference call, a webcast of the call will be available...

Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

Written by Customer Service on March 24, 2023. Posted in Earnings Releases And Operating Results.

Reprioritized product portfolio to focus on IV-administered, self-amplifying RNA medicines On track to submit IND for ONCR-021 in mid-2023 Preclinical data featured in Nature Communications support self-amplifying RNA platform and promise of repeat IV-administration Ended the quarter with $62.2 million in cash, cash equivalents and investments to support next-generation RNA therapeutics pipelineANDOVER, Mass., March 24, 2023 (GLOBE NEWSWIRE) — Oncorus, Inc. (Nasdaq: ONCR), an RNA medicines company focused on developing intravenously administered, self-amplifying RNA to transform outcomes for cancer patients, today reported fourth quarter and full year 2022 financial results and provided an update on its business. “We are poised for a year of strong execution as we head further into 2023. Oncorus is pioneering a first-of-its-kind,...

Humacyte Announces Fourth Quarter and Year End 2022 Financial Results and Business Update

Written by Customer Service on March 24, 2023. Posted in Earnings Releases And Operating Results.

— Enrollment Nearing Completion in Human Acellular Vessel™ (HAV™) Phase 2/3 Trial in Vascular Trauma and Phase 3 Trial in Arteriovenous (AV) Access in Hemodialysis Patients — Multiple publications and scientific meeting presentations highlighting clinical and preclinical HAV results – — Conference call and live webcast at 8:00 a.m. ET today – DURHAM, N.C., March 24, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues and advanced tissue constructs and organ systems at commercial scale, today announced financial results for the fourth quarter and year ended December 31, 2022, and highlighted recent corporate accomplishments. “During 2022, we continued to make significant progress...

Grace Breeding Reports 2022 Full-Year Financial Results

Written by Customer Service on March 24, 2023. Posted in Earnings Releases And Operating Results.

– Program developments throughout 2022, and, to date in 2023, bring Grace Breeding closer to offering crop solutions to farmers aligned with environmental responsibility and reversing climate change – REHOVOT, Israel, March 24, 2023 (GLOBE NEWSWIRE) — Grace Breeding Ltd. (the “Company” or “Grace Breeding”) (TASE: GRAC), a forward-thinking AgClimateTech company developing biological-based products to improve crop yield and vigor today reported full-year financial results for the period ending December 31, 2022. “In 2022 just after taking the company public, and so far in 2023, we have made great strides to advance our NFT and WDS programs in parallel, bringing us closer towards our goal to sustainably address upstream and downstream solutions for the crop life cycle,” stated Assaf Dotan, Chief...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals